Adverse effects linked to prescribed medications in a periodontology clinic
Official title: Evaluation of Adverse Effects Related to Prescribed Medications in a Periodontology Clinic in Terms of Causality, Severity, and Quality of Life: A Prospective Study
Run by Cumhuriyet University · NCT07666100 · Data updated 2026-11-12
This observational study tests whether side effects from drugs prescribed in a periodontal clinic are identifiable and linked to specific medications in patients 16 and older.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 571 (estimated) |
| Sponsor | Cumhuriyet University Academic / other |
| Locations | 1 site (Sivas) |
| Status | Recruiting |
| Started | March 30, 2026 |
| Main results expected | July 30, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | June 26, 2026 |
| Trial ID | NCT07666100 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are periodontal patients aged 16 or older who have been prescribed at least one pharmacologic agent and are willing to provide informed consent and follow-up data.
✕Probably not a fit
Patients who do not experience adverse effects or whose side effects are unrelated to their medications may not directly benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study uses a questionnaire to collect information on drug-related side effects among patients treated in a periodontology clinic who have been prescribed pharmacological agents. It aims to identify and categorize adverse events, explore potential causality, and describe severity to support pharmacovigilance practices. The project references data sources like the FDA FAERS and emphasizes the importance of early adverse event detection for patient safety and treatment adherence. Eligibility includes patients 16 years or older who are receiving periodontal care and have at least one prescribed drug, with informed consent and adequate follow-up data. Exclusion criteria include cognitive impairment and incomplete or unreliable follow-up information.
Why it matters
Potential benefit: If successful, the study could improve detection and management of drug-related side effects in periodontal care, potentially enhancing patient safety and treatment success.
How similar studies have gone: Pharmacovigilance efforts in dental care have shown value in identifying drug-related adverse events, though specific peri- odontologic dataset analyses may be limited and this approach adds observational insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Being 16 years of age or older * Receiving treatment at a periodontology clinic • Having been prescribed at least one pharmacological agent * Volunteering to participate in the study and providing informed consent Exclusion Criteria: * Having a cognitive problem that would prevent the evaluation of side effects related to drug use * Patients who did not come for evaluation during the follow-up period or for whom sufficient follow-up data could not be obtained * Patients who provided incomplete, inconsistent or unreliable data regarding side effect evaluation
Where it's running
-
Sivas Cumhuriyet University
Sivas, Turkey (Türkiye) Recruiting
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.